
Group Structure
View All
Industry
Other research and experimental development on natural sciences and engineering
+1Registered Address
unit 10 42-44 bridge street, westway house, newton-le-willows, WA12 9QT
Pomanda estimates the enterprise value of INSTITUTE OF MEDICAL ETHICS at £265.4k based on a Turnover of £325.1k and 0.82x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of INSTITUTE OF MEDICAL ETHICS at £104.7k based on an EBITDA of £26.2k and a 4x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of INSTITUTE OF MEDICAL ETHICS at £2.4m based on Net Assets of £1.1m and 2.18x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Institute Of Medical Ethics is a live company located in newton-le-willows, WA12 9QT with a Companies House number of 00985158. It operates in the other research and experimental development on natural sciences and engineering sector, SIC Code 72190. Founded in July 1970, it's largest shareholder is unknown. Institute Of Medical Ethics is a mature, micro sized company, Pomanda has estimated its turnover at £325.1k with healthy growth in recent years.
Pomanda's financial health check has awarded Institute Of Medical Ethics a 5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 4 areas for improvement. Company Health Check FAQs
5 Strong
2 Regular
4 Weak
Size
annual sales of £325.1k, make it smaller than the average company (£2.6m)
£325.1k - Institute Of Medical Ethics
£2.6m - Industry AVG
Growth
3 year (CAGR) sales growth of 9%, show it is growing at a faster rate (5.7%)
9% - Institute Of Medical Ethics
5.7% - Industry AVG
Production
with a gross margin of 58.8%, this company has a comparable cost of product (58.8%)
58.8% - Institute Of Medical Ethics
58.8% - Industry AVG
Profitability
an operating margin of 7.6% make it more profitable than the average company (2.9%)
7.6% - Institute Of Medical Ethics
2.9% - Industry AVG
Employees
with 3 employees, this is below the industry average (29)
3 - Institute Of Medical Ethics
29 - Industry AVG
Pay Structure
on an average salary of £23.8k, the company has a lower pay structure (£56.1k)
£23.8k - Institute Of Medical Ethics
£56.1k - Industry AVG
Efficiency
resulting in sales per employee of £108.4k, this is equally as efficient (£117.5k)
£108.4k - Institute Of Medical Ethics
£117.5k - Industry AVG
Debtor Days
it gets paid by customers after 344 days, this is later than average (39 days)
344 days - Institute Of Medical Ethics
39 days - Industry AVG
Creditor Days
its suppliers are paid after 21 days, this is quicker than average (37 days)
21 days - Institute Of Medical Ethics
37 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Institute Of Medical Ethics
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 1395 weeks, this is more cash available to meet short term requirements (66 weeks)
1395 weeks - Institute Of Medical Ethics
66 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 1.2%, this is a lower level of debt than the average (35.6%)
1.2% - Institute Of Medical Ethics
35.6% - Industry AVG
Institute Of Medical Ethics's latest turnover from December 2023 is £325.1 thousand and the company has net assets of £1.1 million. According to their latest financial statements, Institute Of Medical Ethics has 3 employees and maintains cash reserves of £360 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 325,128 | 260,009 | 388,432 | 252,507 | 285,680 | 320,463 | 272,188 | 227,906 | 182,051 | 151,609 | 141,664 | 161,279 | 150,278 | 96,271 | 87,491 |
Other Income Or Grants | |||||||||||||||
Cost Of Sales | |||||||||||||||
Gross Profit | |||||||||||||||
Admin Expenses | |||||||||||||||
Operating Profit | |||||||||||||||
Interest Payable | |||||||||||||||
Interest Receivable | |||||||||||||||
Pre-Tax Profit | 33,287 | -21,795 | 233,022 | 74,054 | 39,693 | 8,350 | 47,518 | 61,082 | 29,266 | 16,672 | 15,795 | 92,645 | 89,658 | 35,428 | 32,590 |
Tax | |||||||||||||||
Profit After Tax | 33,287 | -21,795 | 233,022 | 74,054 | 39,693 | 8,350 | 47,518 | 61,082 | 29,266 | 16,672 | 15,795 | 92,645 | 89,658 | 35,428 | 32,590 |
Dividends Paid | |||||||||||||||
Retained Profit | 33,287 | -21,795 | 233,022 | 74,054 | 39,693 | 8,350 | 47,518 | 61,082 | 29,266 | 16,672 | 15,795 | 92,645 | 89,658 | 35,428 | 32,590 |
Employee Costs | 71,485 | 86,108 | 81,072 | 69,428 | 67,617 | 67,882 | 64,746 | 62,332 | 60,413 | 61,860 | 44,484 | ||||
Number Of Employees | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 5,406 | 4,108 | 3,594 | 4,188 | 4,069 | 3,109 | 4,191 | 5,621 | 6,511 | 8,496 | 9,734 | ||||
Intangible Assets | |||||||||||||||
Investments & Other | 407,422 | 414,121 | 429,046 | 339,326 | 320,052 | 161,546 | 47,538 | 45,180 | 43,013 | 42,607 | 42,521 | 38,484 | 34,889 | 37,132 | 35,293 |
Debtors (Due After 1 year) | |||||||||||||||
Total Fixed Assets | 412,828 | 418,229 | 432,640 | 343,514 | 324,121 | 164,655 | 51,729 | 50,801 | 49,524 | 51,103 | 52,255 | 38,484 | 34,889 | 37,132 | 35,293 |
Stock & work in progress | |||||||||||||||
Trade Debtors | 307,255 | 243,928 | 253,565 | 224,925 | 224,927 | ||||||||||
Group Debtors | |||||||||||||||
Misc Debtors | 33,802 | 31,531 | 37,201 | 9,169 | 5,664 | 214,782 | 188,660 | 186,599 | 146,366 | 140,678 | 134,921 | 141,057 | 131,434 | 78,475 | 68,531 |
Cash | 359,996 | 395,602 | 388,735 | 291,498 | 236,373 | 368,632 | 508,048 | 462,282 | 435,017 | 400,457 | 386,834 | 374,638 | 291,315 | 257,516 | 231,402 |
misc current assets | |||||||||||||||
total current assets | 701,053 | 671,061 | 679,501 | 525,592 | 466,964 | 583,414 | 696,708 | 648,881 | 581,383 | 541,135 | 521,755 | 515,695 | 422,749 | 335,991 | 299,933 |
total assets | 1,113,881 | 1,089,290 | 1,112,141 | 869,106 | 791,085 | 748,069 | 748,437 | 699,682 | 630,907 | 592,238 | 574,010 | 554,179 | 457,638 | 373,123 | 335,226 |
Bank overdraft | |||||||||||||||
Bank loan | |||||||||||||||
Trade Creditors | 7,915 | 5,266 | 11,657 | 5,633 | 6,769 | 3,002 | 6,939 | 6,156 | 3,478 | ||||||
Group/Directors Accounts | |||||||||||||||
other short term finances | |||||||||||||||
hp & lease commitments | |||||||||||||||
other current liabilities | 5,495 | 16,840 | 11,505 | 7,516 | 2,413 | 2,949 | 9,730 | 11,636 | 8,788 | 3,269 | 1,800 | 1,800 | 1,499 | 4,399 | 3,769 |
total current liabilities | 13,410 | 22,106 | 23,162 | 13,149 | 9,182 | 5,951 | 16,669 | 17,792 | 12,266 | 3,269 | 1,800 | 1,800 | 1,499 | 4,399 | 3,769 |
loans | |||||||||||||||
hp & lease commitments | |||||||||||||||
Accruals and Deferred Income | |||||||||||||||
other liabilities | |||||||||||||||
provisions | |||||||||||||||
total long term liabilities | |||||||||||||||
total liabilities | 13,410 | 22,106 | 23,162 | 13,149 | 9,182 | 5,951 | 16,669 | 17,792 | 12,266 | 3,269 | 1,800 | 1,800 | 1,499 | 4,399 | 3,769 |
net assets | 1,100,471 | 1,067,184 | 1,088,979 | 855,957 | 781,903 | 742,118 | 731,768 | 681,890 | 618,641 | 588,969 | 572,210 | 552,379 | 456,139 | 368,724 | 331,457 |
total shareholders funds | 1,100,471 | 1,067,184 | 1,088,979 | 855,957 | 781,903 | 742,118 | 731,768 | 681,890 | 618,641 | 588,969 | 572,210 | 552,379 | 456,139 | 368,724 | 331,457 |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | |||||||||||||||
Depreciation | 1,602 | 1,275 | 1,073 | 938 | 1,413 | 1,082 | 1,429 | 1,729 | 2,156 | 2,588 | 1,391 | ||||
Amortisation | |||||||||||||||
Tax | |||||||||||||||
Stock | |||||||||||||||
Debtors | 65,598 | -15,307 | 56,672 | 3,503 | 15,809 | 26,122 | 2,061 | 40,233 | 5,688 | 5,757 | -6,136 | 9,623 | 52,959 | 9,944 | 68,531 |
Creditors | 2,649 | -6,391 | 6,024 | -1,136 | 3,767 | -3,937 | 783 | 2,678 | 3,478 | ||||||
Accruals and Deferred Income | -11,345 | 5,335 | 3,989 | 5,103 | -536 | -6,781 | -1,906 | 2,848 | 5,519 | 1,469 | 301 | -2,900 | 630 | 3,769 | |
Deferred Taxes & Provisions | |||||||||||||||
Cash flow from operations | |||||||||||||||
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | -6,699 | -14,925 | 89,720 | 19,274 | 158,506 | 114,008 | 2,358 | 2,167 | 406 | 86 | 4,037 | 3,595 | -2,243 | 1,839 | 35,293 |
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | |||||||||||||||
Group/Directors Accounts | |||||||||||||||
Other Short Term Loans | |||||||||||||||
Long term loans | |||||||||||||||
Hire Purchase and Lease Commitments | |||||||||||||||
other long term liabilities | |||||||||||||||
share issue | |||||||||||||||
interest | |||||||||||||||
cash flow from financing | 92 | 2,000 | 2,360 | 2,167 | 406 | 87 | 4,036 | 3,595 | -2,243 | 1,839 | 298,867 | ||||
cash and cash equivalents | |||||||||||||||
cash | -35,606 | 6,867 | 97,237 | 55,125 | -132,259 | -139,416 | 45,766 | 27,265 | 34,560 | 13,623 | 12,196 | 83,323 | 33,799 | 26,114 | 231,402 |
overdraft | |||||||||||||||
change in cash | -35,606 | 6,867 | 97,237 | 55,125 | -132,259 | -139,416 | 45,766 | 27,265 | 34,560 | 13,623 | 12,196 | 83,323 | 33,799 | 26,114 | 231,402 |
Perform a competitor analysis for institute of medical ethics by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other micro companies, companies in WA12 area or any other competitors across 12 key performance metrics.
INSTITUTE OF MEDICAL ETHICS group structure
Institute Of Medical Ethics has no subsidiary companies.
Ultimate parent company
INSTITUTE OF MEDICAL ETHICS
00985158
Institute Of Medical Ethics currently has 16 directors. The longest serving directors include Mr Bryan Vernon (Sep 2006) and Dr Wing Kong (Apr 2008).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Bryan Vernon | 74 years | Sep 2006 | - | Director | |
Dr Wing Kong | 57 years | Apr 2008 | - | Director | |
Dr Carwyn Hooper | England | 44 years | May 2013 | - | Director |
Dr Ruth Bromley | England | 50 years | Sep 2014 | - | Director |
Dr Lucy Frith | England | 60 years | Jun 2015 | - | Director |
Ms Georgia Testa | England | 63 years | Jun 2015 | - | Director |
Dr Alexis Paton | England | 40 years | Sep 2019 | - | Director |
Ms Chantal Patel | England | 69 years | Sep 2019 | - | Director |
Mr Christopher Whitehouse | England | 63 years | Sep 2021 | - | Director |
Mr Christopher Whitehouse | England | 63 years | Sep 2021 | - | Director |
P&L
December 2023turnover
325.1k
+25%
operating profit
24.5k
0%
gross margin
58.8%
-2.78%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
1.1m
+0.03%
total assets
1.1m
+0.02%
cash
360k
-0.09%
net assets
Total assets minus all liabilities
company number
00985158
Type
Private Ltd By Guarantee w/o Share Cap
industry
72190 - Other research and experimental development on natural sciences and engineering
94120 - Activities of professional membership organisations
incorporation date
July 1970
age
55
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
December 2023
previous names
society for the study of medical ethics (August 1984)
accountant
JENNIFER DANIEL
auditor
-
address
unit 10 42-44 bridge street, westway house, newton-le-willows, WA12 9QT
Bank
CAF BANK LIMITED
Legal Advisor
-
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to institute of medical ethics.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for INSTITUTE OF MEDICAL ETHICS. This can take several minutes, an email will notify you when this has completed.
date | description | view/download |
---|